Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

85.01
+0.40000.47%
Post-market: 85.030.0200+0.02%16:24 EDT
Volume:221.34K
Turnover:18.81M
Market Cap:3.55B
PE:- -
High:85.25
Open:84.62
Low:84.54
Close:84.61
52wk High:85.46
52wk Low:64.30
Shares:41.75M
Float Shares:41.75M
Volume Ratio:1.02
T/O Rate:0.53%
Dividend:1.02
Dividend Rate:1.20%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Merck Shares Rise 1.9% Premarket

THOMSON REUTERS
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Safety Profiles of Intismeran and Keytruda in Trial were Consistent with Prior Reported Studies for the Combination

THOMSON REUTERS
·
Aug 19

Merck: Phase 3 Interpath-001 Trial of Intismeran Autogene Plus Keytruda Met Primary Endpoint of Recurrence Free Survival

THOMSON REUTERS
·
Aug 19

Merck: Co, Moderna Announce Positive Results from Phase 3 Interpath-001 Trial for Patients with Completely Resected Stage Iib-Iv Melanoma

THOMSON REUTERS
·
Aug 19

Merck: Co, Moderna Will Engage with Regulators on Filing Submissions for Intismeran Autogene in Combination with Keytruda

THOMSON REUTERS
·
Aug 19

Novo Begins Study to Find Lowest Effective Dose for Wegovy Pill

Reuters
·
Aug 19

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19

Jefferies Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G

TIPRANKS
·
Aug 19

J&J EVP Jennifer Taubert Disposes of 15,000 Common Shares for $3.95 Million

Reuters
·
Aug 19

Health Care up on Defensive Bias - Health Care Roundup

Dow Jones
·
Aug 19

AbbVie EVP, Chief Business and Strategy Officer Nicholas Donoghoe Disposes of 32,710 Common Shares Worth $8.18 Million

Reuters
·
Aug 19